Everything You Need to Know About Tularemia

Overview

Tularemia (also called rabbit fever or hare disease) is a rare but serious bacterial infection caused by Francisella tularensis. The organism is highly infectious; as few as 10–50 organisms can cause disease in a healthy adult. Tularemia can affect humans and a wide range of animals, especially rabbits, hares, rodents, and occasionally domestic pets.

Who it affects: The disease occurs worldwide but is most common in the United States, Scandinavia, parts of Russia, and central Asia. In the U.S., most cases are reported from the southcentral states (Arkansas, Missouri, Oklahoma) and the south‑central Great Plains. Children and older adults are at slightly higher risk because of more frequent outdoor activities and a less robust immune response.

Prevalence: According to the U.S. Centers for Disease Control and Prevention (CDC), there are typically 100–200 reported cases per year in the United States, with a slight upward trend in the last decade (CDC, 2023). Worldwide, an estimated 2,000–3,000 cases are reported annually, though the true incidence is likely higher due to under‑reporting.

Symptoms

Symptoms vary depending on the route of infection (skin, inhalation, ingestion, or animal bite) and the form of the disease. Below is a comprehensive list, grouped by the most common clinical presentations.

1. Ulceroglandular (most common, 70% of cases)

• Skin ulcer: A painless papule or vesicle appears at the site of entry (often a tick bite) and evolves into an ulcer with a raised, red border.
• Swollen lymph nodes: Tender, enlarged lymph nodes (bubo) develop near the ulcer, usually within 3–5 days.
• Fever, chills, headache, and malaise often accompany the local findings.

2. Glandular

• Enlarged, painful lymph nodes without an associated skin ulcer.
• Systemic symptoms similar to the ulceroglandular form.

3. Ophthalmic (Oculoglandular)

• Red, painful eye (conjunctivitis) with swelling of nearby lymph nodes.
• Blurred vision, tearing, and sensitivity to light.

4. Respiratory (Pneumonic)

• Dry cough, chest pain, and shortness of breath.
• Fever, chills, and night sweats.
• On chest X‑ray: infiltrates that can mimic pneumonia or, in severe cases, acute respiratory distress syndrome (ARDS).

5. Typhoidal

• High fever (often > 103°F / 39.5°C), severe headache, abdominal pain, and diarrhea or constipation.
• May lack any obvious skin lesion or lymphadenopathy, making diagnosis challenging.

6. Gastrointestinal

• Abdominal pain, nausea, vomiting, and bloody or mucoid diarrhea.
• Fever and possible hepatosplenomegaly.

7. Septicemic

• Rapidly progressive fever, low blood pressure, shock, and multi‑organ failure.
• Often a complication of other forms when the bacteria spread through the bloodstream.

Note: Incubation period ranges from 3 to 14 days (average 5–7 days). Symptoms usually appear suddenly and can progress quickly, especially in the pneumonic and septicemic forms.

Causes and Risk Factors

What causes Tularemia?

The disease is caused by the gram‑negative bacterium Francisella tularensis. Three subspecies are clinically relevant:

• F. tularensis subsp. tularensis (Type A): Highly virulent, responsible for most severe cases in North America.
• F. tularensis subsp. holarctica (Type B): Less virulent, more common in Europe and Asia.
• F. tularensis subsp. mediasiatica: Rare, reported primarily in Central Asia.

Transmission pathways

• Tick or deer fly bite: The most frequent route in the United States.
• Contact with infected animals: Skinning, cleaning, or handling carcasses of rabbits, rodents, or other wildlife.
• Inhalation of contaminated aerosols: Often occupational (lab workers, hunters) or during landscaping/dust‑raising activities.
• Ingestion: Consuming contaminated water or undercooked meat.
• Laboratory exposure: Accidental inoculation or aerosolization.

Risk factors

• Living or working in rural or wooded areas with high rodent or rabbit populations.
• Outdoor occupations: farmers, hunters, wildlife biologists, landscapers, park rangers.
• Recreational activities such as camping, hiking, or fishing in endemic regions.
• Immunocompromised status (e.g., HIV, cancer chemotherapy, organ transplant).
• Age < 5 years or > 65 years, due to less robust immunity.

Diagnosis

Early diagnosis is essential because appropriate antibiotics dramatically reduce morbidity and mortality. Diagnosis relies on a combination of clinical suspicion, exposure history, and laboratory testing.

Laboratory Tests

• Culture: Gold standard but requires Biosafety Level 3 facilities. Blood, tissue, or throat swabs can be cultured on chocolate agar; results may take 3–5 days.
• Serology: Detection of specific IgM and IgG antibodies. A single‑sample titer ≥ 1:160 is suggestive; a ≥ four‑fold rise in paired samples (2–4 weeks apart) confirms infection.
• Polymerase Chain Reaction (PCR): Rapid (hours) detection of bacterial DNA from blood, tissue, or respiratory secretions. Widely used in reference labs.
• Antigen detection (e.g., rapid immunoassays): Available in some regions but less sensitive than PCR.

Imaging

• Chest X‑ray or CT: For pneumonic tularemia, shows infiltrates, nodules, or pleural effusion.
• Ultrasound: May identify enlarged lymph nodes or abscesses in ulceroglandular disease.

Clinical criteria

In endemic areas, a clinician may start empiric therapy if a patient presents with fever plus any of the characteristic signs (e.g., ulcer with regional lymphadenopathy) after a known tick bite or wildlife exposure.

Treatment Options

Antibiotic therapy is the cornerstone. Choice depends on disease severity, route of infection, patient age, pregnancy status, and antibiotic tolerance.

First‑line antibiotics

• S streptomycin: 1 g IM or IV every 12 h for 7–10 days (CDC Preferred). Requires renal dosing adjustments.
• Gentamicin: 5 mg/kg/day divided every 8 h IV/IM for 7–10 days (alternative to streptomycin).
• Doxycycline: 100 mg PO/IV every 12 h for 14–21 days. Often used for milder cases or when aminoglycosides are contraindicated.
• Ciprofloxacin: 500 mg PO/IV every 12 h for 14–21 days. Recommended for children and pregnant women when doxycycline is not suitable.

Second‑line agents

• Chloramphenicol (used historically, now less common due to toxicity).
• Azithromycin (limited data, may be considered in macrolide‑allergic patients).

Supportive care

• Fluid resuscitation and electrolytes for septicemic or typhoidal forms.
• Oxygen therapy or mechanical ventilation for severe pneumonic disease.
• Analgesics and antipyretics for symptom control.

Lifestyle adjustments during treatment

• Complete the full antibiotic course—even if symptoms improve.
• Rest and avoid strenuous activity while fever persists.
• Maintain good hydration and nutrition.

Living with Tularemia

Most patients recover fully with prompt treatment, but some may experience lingering effects. Below are practical tips for daily management.

Post‑treatment monitoring

• Schedule a follow‑up visit 2–4 weeks after completing antibiotics to ensure symptom resolution and to repeat serology if needed.
• Watch for delayed complications such as lymph node calcification or residual joint pain.

Managing residual symptoms

• Fatigue: Gradually increase activity levels; consider short, frequent walks.
• Joint or muscle aches: Over‑the‑counter NSAIDs (if no contraindications) and gentle stretching.
• Skin healing: Keep ulcer sites clean, apply sterile dressings, and avoid picking scabs.

Psychosocial support

Because tularemia is uncommon, patients may feel isolated. Encourage joining local or online support groups for rare infectious diseases, and discuss any anxiety with a primary‑care provider.

Prevention

Prevention focuses on minimizing exposure to the bacterium and protecting against tick bites.

• Tick avoidance: Wear long sleeves, long pants, and light‑colored clothing when in wooded or brushy areas. Use EPA‑registered repellents containing DEET, picaridin, or IR3535 on skin and permethrin on clothing.
• Tick checks: Perform a full‑body inspection within 24 hours after outdoor activities; remove attached ticks with fine‑point tweezers.
• Animal handling: Wear gloves and protective clothing when skinning, cleaning, or examining wild animals; disinfect tools and surfaces.
• Water safety: Avoid drinking untreated water from surface sources in endemic regions; use filters capable of removing bacteria (0.2 µm) or boil water for at least 1 minute.
• Food safety: Cook wild game to an internal temperature of ≥ 165 °F (74 °C). Freeze meat for ≥ 48 hours at –4 °F (–20 °C) before consumption.
• Laboratory safety: Follow Biosafety Level 3 protocols when handling cultures; use appropriate personal protective equipment (PPE).
• Vaccination: No licensed vaccine is available for the general public, though experimental vaccines are used in research labs.

Complications

If untreated or inadequately treated, tularemia can lead to serious, sometimes life‑threatening complications.

• Pneumonia and ARDS: Particularly with inhalational exposure; mortality can exceed 30 % without prompt therapy.
• Septic shock: Rapid progression to multi‑organ failure.
• Chronic lymphadenitis: Persistent swollen nodes that may calcify or form draining sinuses.
• Ocular damage: In oculoglandular disease, corneal ulceration or vision loss may occur.
• Hepatosplenic involvement: Hepatitis or splenic infarcts in severe systemic disease.
• Relapse: Inadequate antibiotic duration can cause recurrence; reported in 5–10 % of cases.

When to Seek Emergency Care

---

Sources: CDC – Tularemia; Mayo Clinic; World Health Organization (WHO); NIH – Clinical Review of Tularemia; Cleveland Clinic.